Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives

Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives

Abstract Background Oxidative stress may be involved in the pathophysiology of bipolar disorder (BD). Malondialdehyde (MDA), a product of fatty acid peroxidation has been proposed as a trait marker of BD associated with familial risk. However, little is known about MDA levels in young patients newly...

Full description

Saved in:
Bibliographic Details
Main Authors: Sharleny Stanislaus, Klara Coello, Hanne Lie Kjaerstad, Kimie Stefanie Ormstrup Sletved, Kamilla Woznica Miskowiak, Maria Faurholt-Jepsen, Klaus Munkholm, Henrik Enghusen Poulsen, Maj Vinberg, Jens Lykkesfeldt, Lars V. Kessing
Format: Article
Language:English
Published: SpringerOpen 2025-03-01
Series:International Journal of Bipolar Disorders
Subjects:
Bipolar disorders
Lipid oxidation
Malondialdehyde
High-risk
Adolescence
Online Access:https://doi.org/10.1186/s40345-025-00377-8
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Oxidative stress may be involved in the pathophysiology of bipolar disorder (BD). Malondialdehyde (MDA), a product of fatty acid peroxidation has been proposed as a trait marker of BD associated with familial risk. However, little is known about MDA levels in young patients newly diagnosed with BD and their unaffected first-degree relatives (UR). Methods In this substudy of the ongoing longitudinal “Bipolar Illness Onset study”, we included baseline data and first, we compared fasting blood MDA levels in 130 young patients aged 15–25 years newly diagnosed with BD, 57 UR, and 88 healthy control individuals (HC). Second, we investigated associations between levels of MDA and illness variables in patients with BD. Third, we investigated associations between MDA levels and nucleoside damage by oxidation measured in urine. Fasting MDA levels from blood samples were measured using high-performance liquid chromatography (HPLC). Results In linear mixed effect models, adjusted for age and sex, MDA levels did not differ between patients with BD, UR, and HC, respectively. In patients with BD, we found no associations between levels of MDA and duration of illness, number of affective phases, illness onset or oxidatively damaged RNA and DNA. Conclusion Against expectations, MDA levels did not differ between young patients with BD, UR, and HC, thus, our findings did not support MDA being a state or a trait marker of BD associated with familial risk.
ISSN:2194-7511

Similar Items